Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Pemigatinib by Incyte for Non-Small Cell Lung Cancer: Likelihood of Approval
Pemigatinib is under clinical development by Incyte and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...
Pemigatinib by Incyte for Breast Cancer: Likelihood of Approval
Pemigatinib is under clinical development by Incyte and currently in Phase II for Breast Cancer. According to GlobalData, Phase II...
Pemigatinib by Incyte for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer): Likelihood of Approval
Pemigatinib is under clinical development by Incyte and currently in Phase II for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial...
Pemigatinib by Incyte for Squamous Non-Small Cell Lung Cancer: Likelihood of Approval
Pemigatinib is under clinical development by Incyte and currently in Phase II for Squamous Non-Small Cell Lung Cancer. According to...